Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SOLY

Soliton (SOLY) Stock Price, News & Analysis

Soliton logo

About Soliton Stock (NASDAQ:SOLY)

Advanced Chart

Key Stats

Today's Range
$22.58
$22.58
50-Day Range
$20.10
$22.58
52-Week Range
$7.40
$22.60
Volume
N/A
Average Volume
347,827 shs
Market Capitalization
$487.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Soliton, Inc. is a medical development company, which engages in the development of healthcare technological devices for medical and cosmetic treatments. Its technology platform include Rapid Acoustic Pulse, a device uses rapid pulses of designed acoustic shockwaves to disrupt cellular structures in the dermal and subdermal tissue. The firm is also in the pre-revenue stage with its first products being developed for the removal of tattoos and the reduction of cellulite. The company was founded by Walter V. Klemp and Christopher Capelli on March 27, 2012 and is headquartered in Houston, TX.

Receive SOLY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Soliton and its competitors with MarketBeat's FREE daily newsletter.

SOLY Stock News Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
General Maximum - Seeking Alpha
See More Headlines

SOLY Stock Analysis - Frequently Asked Questions

Soliton, Inc. (NASDAQ:SOLY) issued its quarterly earnings results on Thursday, August, 12th. The company reported ($0.37) EPS for the quarter, missing analysts' consensus estimates of ($0.30) by $0.07.

Based on aggregate information from My MarketBeat watchlists, some other companies that Soliton investors own include BMO Capital Markets (), Stifel Nicolaus (), Wunderlich (), Standpoint Research (), Duncan Williams (), Soleil Securities () and Sterne Agee CRT ().

Company Calendar

Last Earnings
8/12/2021
Today
5/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:SOLY
Fax
N/A
Employees
14
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.54 million
Pretax Margin
-4,831.89%

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$1.46 per share
Price / Book
15.47

Miscellaneous

Free Float
19,005,000
Market Cap
$487.66 million
Optionable
Not Optionable
Beta
0.19
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:SOLY) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners